ArticleEndocrine connections2023
Long-term, real-world experience of pasireotide dose reduction in patients with acromegaly.
Nelma Veronica Marques et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this paperpooled itcites it